- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/06 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 401/06
Total number of patents in this class: 4713
10-year publication summary
|
395
|
311
|
344
|
400
|
344
|
304
|
280
|
310
|
221
|
142
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2713 |
96 |
| Janssen Pharmaceutica N.V. | 3392 |
92 |
| Merck Sharp & Dohme LLC | 3748 |
79 |
| Bristol-myers Squibb Company | 4898 |
71 |
| F. Hoffmann-La Roche AG | 7925 |
71 |
| Boehringer Ingelheim International GmbH | 4650 |
71 |
| Novartis AG | 10849 |
65 |
| VALO Health, Inc. | 172 |
53 |
| Merck Patent GmbH | 5831 |
40 |
| The Regents of the University of California | 19918 |
37 |
| Eli Lilly and Company | 3842 |
37 |
| Syngenta Crop Protection AG | 6054 |
34 |
| Allergan, Inc. | 2349 |
34 |
| AstraZeneca AB | 2909 |
33 |
| Centre National de La Recherche Scientifique | 10418 |
33 |
| Mycovia Pharmaceuticals, Inc. | 41 |
33 |
| Toray Industries, Inc. | 6936 |
32 |
| ChemoCentryx, Inc. | 385 |
32 |
| Astellas Pharma Inc. | 1088 |
30 |
| Hoffmann-La Roche Inc. | 3418 |
29 |
| Other owners | 3711 |